News from the healthcare data industry
Powered by Komodo’sHealthcare Map™, Provider Finder connects patients with top specialists by geography and expertise March 16, 2022 08:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS WIRE)–Today, Komodo Health and Fight Colorectal...
The partnership will unlock new use cases across clinical development, medical affairs, HEOR, and commercial functions March 16, 2022 08:45 ET | Source: Datavant SAN FRANCISCO, March 16, 2022 (GLOBE NEWSWIRE) —...
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM...
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM...
SHANGHAI, March 14, 2022 /PRNewswire/ — Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases, announced that the...
Combined technologies strengthen Clarify’s leadership, creating the most comprehensive end-to-end value-based payments solution March 14, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and...
Program open at no-cost to any academic researcher interested in submitting a proposal March 10, 2022 08:00 AM Eastern Standard Time OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) and the University of Oxford...
Tyra Biosciences supported study investigates if non-invasive blood and urine samples provide biomarkers to assess clinical response to erdafitinib treatment OAKLAND, CALIFORNIA, UNITED STATES, March 10, 2022 /EINPresswire.com/ — Today,...